Diffuse intrapulmonary malignant mesothelioma presenting with miliary pulmonary nodules: A case report

被引:6
作者
Hida, Tomoyuki [1 ]
Hamasaki, Makoto [1 ]
Matsumoto, Shinji [1 ]
Abe, Sosei [1 ]
Takakura, Koji [2 ]
Hiroshima, Kenzo [3 ]
Nabeshima, Kazuki [1 ]
机构
[1] Fukuoka Univ Hosp, Dept Pathol, Fukuoka, Fukuoka 8140180, Japan
[2] Ohmuta Natl Hosp, Dept Resp Med, Natl Hosp Org, Fukuoka, Japan
[3] Tokyo Womens Med Univ, Dept Pathol, Yachiyo Med Ctr, Yachiyo, Japan
关键词
diffuse intrapulmonary malignant mesothelioma; DIMM; epithelioid; miliary mesothelioma; p16FISH; PLEURAL MESOTHELIOMA; LUNG ADENOCARCINOMA; ASSOCIATION; METASTASES; MUTATIONS; SURVIVAL; DISEASE;
D O I
10.1111/pin.12282
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A 67-year-old male with a history of asbestos exposure presented with fever, cough, and dyspnea and was found to have diffuse granular shadowing in both lungs, right pleural effusion, and hilar and mediastinal lymphadenopathy upon chest computed tomography. For definitive diagnosis, a thoracoscopic lung biopsy was performed. Intraoperative findings showed no remarkable macroscopic changes in the visceral and parietal pleura, although a high level of hyaluronic acid in the pleural effusion was noted. Histological findings showed proliferation of atypical cells with round-to-oval nuclei, prominent nucleoli, and eosinophilic cytoplasms. These cells were arranged into sheets or tubules and were located predominantly in the lung parenchyma. Lymphovascular invasion was conspicuous. Immunohistochemically, tumor cells were positive for calretinin, D2-40, and CK5/6, focally positive for Ber-EP4, but negative for WT-1, TTF-1, CEA, and MOC31. Fluorescence in situ hybridization for the tumor suppressor p16 revealed homozygous deletion in the tumor cells. Therefore, we diagnosed the tumor as diffuse intrapulmonary malignant mesothelioma (DIMM). The patient had a poor response to chemotherapy and died 1 year after diagnosis. Although rare, DIMM should be considered when patients present with multiple, tiny intrapulmonary nodules, regardless of macroscopic pleural changes. Furthermore, this is the first report on p16 status in DIMM.
引用
收藏
页码:318 / 323
页数:6
相关论文
共 20 条
[1]   Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas [J].
Chiosea, Simion ;
Krasinskas, Alyssa ;
Cagle, Philip T. ;
Mitchell, Kisha A. ;
Zander, Dani S. ;
Dacic, Sanja .
MODERN PATHOLOGY, 2008, 21 (06) :742-747
[2]   An association between postoperative radiotherapy for primary breast cancer in 11 National Surgical Adjuvant Breast and Bowel Project (NSABP) studies and the subsequent appearance of pleural mesothelioma [J].
Deutsch, Melvin ;
Land, Stephanie R. ;
Begovic, Mirsada ;
Cecchini, Reena ;
Wolmark, Norman .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03) :294-296
[3]   Treatment and survival analyses of malignant mesothelioma in Japan [J].
Gemba, Kenichi ;
Fujimoto, Nobukazu ;
Aoe, Keisuke ;
Kato, Katsuya ;
Takeshima, Yukio ;
Inai, Kouki ;
Kishimoto, Takumi .
ACTA ONCOLOGICA, 2013, 52 (04) :803-808
[4]   MILIARY MESOTHELIOMA [J].
HUNCHAREK, M .
CHEST, 1994, 106 (02) :605-606
[5]   Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group [J].
Husain, Aliya N. ;
Colby, Thomas ;
Ordonez, Nelson ;
Krausz, Thomas ;
Attanoos, Richard ;
Beasley, Mary Beth ;
Borczuk, Alain C. ;
Butnor, Kelly ;
Cagle, Philip T. ;
Chirieac, Lucian R. ;
Churg, Andrew ;
Dacic, Sanja ;
Fraire, Armando ;
Galateau-Salle, Francoise ;
Gibbs, Allen ;
Gown, Allen ;
Hammar, Samuel ;
Litzky, Leslie ;
Marchevsky, Alberto M. ;
Nicholson, Andrew G. ;
Roggli, Victor ;
Travis, William D. ;
Wick, Mark .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (05) :647-667
[6]   Association of p16 homozygous deletions with clinicopathologic characteristics and EGFR/KRAS/p53 mutations in lung adenocarcinoma [J].
Iwakawa, Reika ;
Kohno, Takashi ;
Anami, Yoichi ;
Noguchi, Masayuki ;
Suzuki, Kenji ;
Matsuno, Yoshihiro ;
Mishima, Kazuhiko ;
Nishikawa, Ryo ;
Tashiro, Fumio ;
Yokota, Jun .
CLINICAL CANCER RESEARCH, 2008, 14 (12) :3746-3753
[7]  
Larsen BT, 2013, AM J SURG PATHOL, V37, P1555, DOI 10.1097/PAS.0b013e3182910c82
[8]  
Livasy Chad A, 2003, Ann Diagn Pathol, V7, P249, DOI 10.1016/S1092-9134(03)00071-6
[9]   Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma [J].
Mezzapelle, R. ;
Miglio, U. ;
Rena, O. ;
Paganotti, A. ;
Allegrini, S. ;
Antona, J. ;
Molinari, F. ;
Frattini, M. ;
Monga, G. ;
Alabiso, O. ;
Boldorini, R. .
BRITISH JOURNAL OF CANCER, 2013, 108 (08) :1743-1749
[10]   Malignant Pleural Mesothelioma A Population-Based Study of Survival [J].
Milano, Michael T. ;
Zhang, Hong .
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (11) :1841-1848